News Summary

• Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd.
• The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss.
• By combining the complementary strengths of both parties, the partnership aims to accelerate the advancement of promising molecules toward clinical and commercial success.
• As of December 31, 2025, more than 350 agreements for therapeutic antibodies and clinical assets have been established globally, including landmark partnerships with leading multinational pharmaceutical companies (MNCs)